Training Inventors of Future Medicines

New educational opportunities immerse HMS students in drug discovery and development

From the moment he wrapped up a visit to Bayer’s offices in Cambridge, Massachusetts, Patrick Loi knew that the work scientists did there was something he had to be a part of.

Loi was in the last year of his PhD program at Harvard, determining his next step. He had been working in a lab at Harvard Medical School developing targeted therapies for different types of tumors, and that day, he heard from scientists at Bayer doing similar work.

Read full article here.